Here are a few intriguing nuggets to get you thinking:
- A study found CBD “promotes neuroprotection through different signal transduction pathways mediated indirectly by cannabinoid receptors.” In short, it may be useful in staving off Alzheimer’s.
- An early study suggests microdosing psychedelics may have benefits.
- Canna Law Blog looks at the “Ketamine Clinic Craze: Legalities and Possibilities.”
- The first crop of ‘shroom stocks have skyrocketed on Canadian exchanges. None trades for more than a dollar, however.
In D.C., the city that blunts the cutting edge, the FDA released a long-awaited report on regulating CBD. It didn’t clarify much.